Intratumor and informatic heterogeneity influence meningioma molecular classification.
Harish N Vasudevan, Abrar Choudhury, Stephanie Hilz, Javier E Villanueva-Meyer, William C Chen, Calixto-Hope G Lucas, Steve E Braunstein, Nancy Ann Oberheim Bush, Nicholas Butowski, Melike Pekmezci, Michael W McDermott, Arie Perry, David A Solomon, Stephen T Magill, David R Raleigh
Author Information
- Harish N Vasudevan: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
- Abrar Choudhury: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
- Stephanie Hilz: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
- Javier E Villanueva-Meyer: Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
- William C Chen: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
- Calixto-Hope G Lucas: Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
- Steve E Braunstein: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
- Nancy Ann Oberheim Bush: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
- Nicholas Butowski: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
- Melike Pekmezci: Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
- Michael W McDermott: Miami Neuroscience Institute, Baptist Health, Miami, FL, USA.
- Arie Perry: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
- David A Solomon: Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
- Stephen T Magill: Department of Neurological Surgery, Northwestern University, Chicago, IL, USA. stephen.magill@northwestern.edu.
- David R Raleigh: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.
No abstract text available.
- J Natl Cancer Inst. 2015 Dec 13;108(5):
[PMID: 26668184]
- Neurol Res. 1999 Dec;21(8):721-6
[PMID: 10596379]
- Neuro Oncol. 2019 Jan 14;21(Suppl 1):i18-i31
[PMID: 30649489]
- Acta Neuropathol. 2019 Aug;138(2):295-308
[PMID: 31069492]
- Nature. 2021 Sep;597(7874):119-125
[PMID: 34433969]
- Neuro Oncol. 2019 Jul 11;21(7):901-910
[PMID: 31158293]
- J Neurooncol. 2019 Dec;145(3):449-459
[PMID: 31729637]
- Nat Commun. 2020 Sep 23;11(1):4803
[PMID: 32968068]
- Neuro Oncol. 2017 May 1;19(5):699-709
[PMID: 28453743]
- Neuro Oncol. 2004 Oct;6(4):290-9
[PMID: 15494096]
- Bioinformatics. 2018 Sep 15;34(18):3217-3219
[PMID: 29897414]
- J Clin Oncol. 2021 Dec 1;39(34):3839-3852
[PMID: 34618539]
- Cancer Discov. 2020 Nov;10(11):1722-1741
[PMID: 32703768]
- J Neurosurg Sci. 1996 Mar;40(1):17-23
[PMID: 8913957]
- Nucleic Acids Res. 2018 Nov 16;46(20):e123
[PMID: 30085201]
- Nat Commun. 2020 Jan 3;11(1):89
[PMID: 31900397]
- Nature. 2018 Mar 22;555(7697):524-528
[PMID: 29539641]
- Cell Rep. 2018 Mar 27;22(13):3672-3683
[PMID: 29590631]
- Lancet Oncol. 2017 May;18(5):682-694
[PMID: 28314689]
- Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21715-21726
[PMID: 31591222]
- J Mol Diagn. 2004 Nov;6(4):316-25
[PMID: 15507670]
- Oncotarget. 2017 Nov 24;8(65):109228-109237
[PMID: 29312603]
- Nat Genet. 2022 May;54(5):649-659
[PMID: 35534562]
- Acta Neuropathol. 2017 Mar;133(3):431-444
[PMID: 28130639]
- J Neurosurg. 2019 Oct 25;:1-10
[PMID: 31653806]
- Neuro Oncol. 2021 Aug 2;23(8):1231-1251
[PMID: 34185076]
- Neuro Oncol. 2022 May 4;24(5):796-808
[PMID: 34508644]
- Neuro Oncol. 2018 Nov 12;20(12):1584-1593
[PMID: 30010853]
- Bioinformatics. 2018 May 15;34(10):1642-1649
[PMID: 29325057]
- Neuro Oncol. 2021 May 5;23(5):783-794
[PMID: 33068421]
- T32 CA151022/NCI NIH HHS
- T32 GM007618/NIGMS NIH HHS
- F32 CA213944/NCI NIH HHS
- F30 CA246808/NCI NIH HHS
- R01 CA262311/NCI NIH HHS
- P50 CA097257/NCI NIH HHS
- DP5 OD021403/NIH HHS
Biomarkers, Tumor
Genetic Heterogeneity
Humans
Informatics
Meningeal Neoplasms
Meningioma
Mutation